Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ameloblastoma
Reports outline ameloblastoma study results from C. Rizzardi et al
June 23rd, 2009
"Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is a recently identified death factor that acts as a potent apoptosis inducer in ameloblastomas. The expression of TRAIL and its receptors (TRAIL-R), and the location of apoptotic cells were, evaluated in 15 cases of ameloblastoma using immunohistochemistry and an in situ DNA nick-end labeling method," scientists writing in the journal Anticancer Research report. "The proliferative activity of ameloblastomas was analyzed by determining the Ki-67 labeling index. TRAIL and TRAIL-R were diffusely expressed in ameloblastomas, without clear correlation with the location of apoptotic cells. Apoptosis and...
Source: Cancer Weekly (2009-06-23)
|
